ArticleCell death & disease2022

Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma.

Xiaochen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.